Pharmaceutical market access has become one of the most strategically consequential disciplines in the industry. As payer scrutiny intensifies, health technology assessment (HTA) bodies expand their influence across major markets, and formulary placement decisions increasingly determine whether an approved drug achieves commercial success, pharmaceutical companies are investing heavily in market access strategy. The consultants who advise them operate in a high-complexity, high-demand environment.
The global pharmaceutical market access consulting market was estimated at over $4 billion in 2023 by Evaluate Pharma, with demand driven by specialty drug launches, biosimilar entry, and the growing influence of value-based contracting. Consulting firms capturing that demand face the familiar scaling problem: client deliverable quality depends on senior consultant engagement, but senior consultants are expensive and limited in number.
Virtual assistants provide a targeted mechanism for extending delivery capacity by absorbing the documentation, research logistics, and communication tasks that currently consume senior consultant hours.
Dossier Preparation and Evidence Compilation Support
A core deliverable in market access consulting is the payer dossier — a structured compilation of clinical, economic, and humanistic evidence supporting a drug's value proposition for formulary consideration. Building a dossier involves systematic literature review, data abstraction, evidence table construction, and document formatting that collectively represent many dozens of hours of work per submission.
Virtual assistants with health economics or systematic review backgrounds can support dossier preparation by executing structured database searches (PubMed, Embase, Cochrane), abstracting data from identified studies into standard evidence tables, compiling formatted citation lists, and maintaining version-controlled document libraries as content evolves through client review cycles. This support allows senior consultants to focus on evidence interpretation and strategic framing rather than the upstream research logistics.
According to ISPOR (the International Society for Pharmacoeconomics and Outcomes Research), systematic literature review and evidence synthesis remain the most time-intensive components of a market access submission — and are therefore the most impactful targets for administrative leverage.
HTA Submission Coordination and Deadline Management
Health technology assessment submissions — to NICE in the UK, G-BA in Germany, HAS in France, or ICER in the United States — follow structured timelines with fixed submission windows. Missing a dossier submission deadline or failing to respond to an HTA body's clarification request within the specified window can result in assessment delays with direct commercial consequences for the client.
Virtual assistants managing HTA project timelines can maintain master submission calendars across the consulting firm's client portfolio, track clarification request due dates and coordinate internal response workflows, maintain correspondence logs with HTA bodies and client regulatory teams, and prepare the submission checklist documentation that ensures completeness before filing. This project management discipline is operationally straightforward but critically important.
Client Communication and Engagement Administration
Market access consulting engagements are relationship-intensive. Project kickoff coordination, steering committee meeting logistics, client review meeting materials preparation, and regular status communication are all tasks that consume consultant time that could otherwise be directed toward strategic analysis.
VAs supporting client engagement administration can schedule and prepare materials for client meetings, maintain engagement-level action item trackers, distribute meeting summaries to client contacts, and manage the project documentation repository. This organizational support keeps engagements running on schedule and client relationships feeling well-managed — both of which are critical to consulting firm reputation and renewal rates.
Business Development and Proposal Support
Pharmaceutical market access consulting is a competitive sector where business development is continuous. Responding to RFPs, preparing capability presentations, tracking pipeline opportunities in the CRM, and coordinating proposal development timelines require consistent administrative attention that senior partners and business development leads rarely have time to fully provide.
Virtual assistants supporting the business development function can maintain the proposal library, compile firm capability documentation for new RFPs, track pipeline opportunity status in the CRM, coordinate proposal writing timelines across contributing consultants, and prepare formatted final proposal documents. This support allows business development leads to focus on client relationship cultivation rather than proposal logistics.
Consulting firms seeking VA support that is fluent in pharmaceutical and health economics terminology should consider providers like Stealth Agents, which places assistants with life sciences and consulting support backgrounds.
The Leverage Argument for Consulting Firms
In a consulting business model, margin is ultimately determined by the ratio of billable senior consultant hours to total delivery cost. Every hour a senior consultant spends on literature searches, document formatting, or scheduling rather than strategic analysis is a drag on that ratio. Virtual assistants systematically improve the leverage ratio — allowing the same number of senior consultants to support more concurrent client engagements without a quality degradation.
Sources
- Evaluate Pharma, "Pharmaceutical Market Access Consulting Market Assessment" (2023)
- ISPOR, "Best Practice Guidelines for Systematic Literature Reviews in Health Technology Assessment" (2023)
- NICE, "HTA Process Timelines and Submission Requirements" (2023 guidance update)